Clinical Trials
Braintumor Website

There are 21 trials:
Facility: Samsung Medical Center
NCT Trial Name# of Centers

NCT02213263

  A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera┬« (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
250

NCT02100696

  A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors
205

NCT02477800

  221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
163

NCT01622868

  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
131

NCT01892345

  A Double Blind Trial To Evaluate The Safety And Efficacy Of Eculizumab In Relapsing NMO Patients (PREVENT Study)
110

NCT01977651

  A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
93

NCT02414165

  P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA
67

NCT02073279

  Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD
59

NCT01838668

  An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
46

NCT02576431

  Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE)
36

NCT03243851

  Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
12

NCT02532569

  Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj
9

NCT01202448

  Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma
2

NCT01301560

  Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis
1

NCT01690364

  Comparison of the Effects of Vecuronium and Cisatracurium on Electrophysiologic Monitoring During Neurosurgery
1

NCT02212496

  Identification the Cause of Cerebral Infarction in Patients With Cancer
1

NCT02342587

  Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer
1

NCT02673788

  Follow-Up Study of Safety and Efficacy of Pneumostem┬« in Premature Infants With Intraventricular Hemorrhage
1

NCT02690324

  The Development of Skin Adhesive Patches for the Monitoring and Prediction of Mental Disorders
1

NCT02768571

  Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke
1

NCT03164798

  Serum BDNF Role as a Biomarker for Stroke Rehabilitation
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites